1. Boominathan, L. (2007). Some facts and thoughts: p73 as a tumor suppressor gene in the network of tumor suppressors. Molecular Cancer, 6, 27.
2. Chen, H. Z., Tsai, S. Y., & Leone, G. (2009). Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat Rev Cancer, 9(11), 785–97.
3. Puig, P., Capodieci, P., Drobnjak, M., Verbel, D., Prives, C., Cordon-Cardo, C., et al. (2003). p73 expression in human normal and tumor tissues: loss of p73alpha expression is associated with tumor progression in bladder cancer. Clinical Cancer Research, 9(15), 5642–5651.
4. Urist, M. J., Di Como, C. J., Lu, M. L., Charytonowicz, E., Verbel, D., Crum, C. P., et al. (2002). Loss of p63 expression is associated with tumor progression in bladder cancer. The American Journal of Pathology, 161(4), 1199–1206.
5. Park, B. J., Lee, S. J., Kim, J. I., Lee, S. J., Lee, C. H., Chang, S. G., et al. (2000). Frequent alteration of p63 expression in human primary bladder carcinomas. Cancer Research, 60(13), 3370–3374.